RBDCOV Talks is a ten-episode series where RBDCOV's leading scientists, researchers, medical professionals and community advocates will take us on a knowledge-packed journey to explore and discuss the world of vaccine clinical trials. In these episodes, we will understand how vaccine clinical trials work and talk through interesting topics such as inclusion criteria in a vaccine clinical trial, personalised vaccines and what exactly immunological memory is.
Lessons Learned: insights, learnings, and takeaways.
As RBDCOV nears its end, what have we truly learned? 📚 Laura Ferrer from HIPRA reflects on the key takeaways, lessons, and insights gained throughout the project—from challenges to breakthroughs.
26 Aug 2025
The Psychosocial Perspective: what participants teach us.
💬 What motivated participants to join? How did they experience the process? And what lessons can we learn from their stories? Join Daniela Rojas Castro from EATG, who has played a leading role in ensuring that the voices of affected communities are not just heard, but actively shape the direction of the project.
26 Aug 2025
It Starts and Ends With Us: Community at the Centre of Research.
How the community engagement campaign was built and why inclusion and diversity in clinical research are more than buzzwords they’re essential for impact? Let’s take a closer look with Tania Sanchis and Apostolos Kalogiannis from EATG, as they share insights about the campaign.
21 Nov 2023
Trial results: what are they main findings and what’s next?
Why is data so crucial? Is it only significant for the scientific community? Let's address the importance of collaboration and data sharing for a health project with Laura Sesma from Zabala Innovation.
21 Nov 2023
What will the direct contribution of RBDCOV be if both clinical trials are proven to be effective?
In this episode, we decode RBDCOV's direct contribution. What if both trials succeed? Let's understand the potential impact on global health with Dr. Antoni Castro from IDIBGI🌐💉
21 Nov 2023
Where are we with COVID-19 and what does the future hold?
Considering how changing the COVID situation is, let's understand where we are with COVID-19 and what the future holds with Dr. Mete Tam from METPHARM.
21 Nov 2023
All about personalised vaccines: what are they and what is their future?
Delves into personalized vaccines. What makes them unique, and what does the future hold for customized immunization? Uncover its potential with Julia García-Prado from IrsiCaixa! 🚀🔍
21 Nov 2023
Why should people living with HIV and other immunocompromising conditions be included in clinical trials similar to the RBDCOV trial?
Shed light on immunocompromised clinical trials inclusion. 🦠 Why involve those with HIV?
Join our conversation with Juanfran C and Arda from EATG to understand better the significance for a more inclusive and effective future.
21 Nov 2023
Why have paediatric and adolescent participants been included in this trial?
Explore the significance of including the youngest in vaccine trials with Pablo Rojo from PENTA. Join us as we discuss the impact on child health and the broader community. 🌍💉
21 Nov 2023
All about immunological memory: what is it, how is it obtained and what is the result?
Unveil the vital role of immunological memory, the key to long-lasting, protective immunity with Pere Soler Palacin from Vall D'Hebron. Understand why vaccinations earn immense respect in the scientific community for bolstering our defenses against infectious diseases. 🌐💪
21 Nov 2023
All about vaccine clinical trials: what are they and how do they work?
Explore the intricate world of vaccine clinical trials with Montse Barceló from VERISTAT. 🧪 What are they, and how do they shape the future of healthcare?
21 Nov 2023
What’s Drug Safety? What is Drug Safety-level safety monitoring like in vaccine clinical trials?
Discover the critical role of Drug Safety in vaccine trials with Helena Belinchon from ASPHALION. 🩺 How do experts ensure safety at every level? Join the safety journey now! 🌟💊
21 Nov 2023
In 5 minutes, what is a recombinant protein vaccine?
🧬Dive into the world of recombinant protein vaccines in just 10 minutes with Antonio Barreiro from HIPRA. Unveil the science behind this innovative approach to HIPRA’s vaccine development.
Reach and audience
Public platform figures. Ratings count people who left a rating, not total listeners.
Spotify
5.0 / 5
3 ratings
Contact RBDCOV Talks
Guest appearances
Books guests
Based on episode analysis; this does not confirm that the show is currently accepting guests.
Host of RBDCOV Talks?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
